Yahoo Poland Wyszukiwanie w Internecie

Zaloguj się

Search results

  1. www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-fullPfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S....

    11 gru 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older; It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:

    • View PDF

      The Pfizer-BioNTech COVID-19 Vaccine has received EUA from...

  2. en.wikipedia.org › wiki › Pfizer–BioNTech_COVID-19_vaccinePfizer–BioNTech COVID-19 vaccine - Wikipedia

    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.

  3. www.cdc.gov › vaccines › phpPfizer COVID-19 Vaccine Summary | Vaccines & Immunizations | CDC

    28 sie 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).

  4. www.pfizer.com › pfizer-and-biontech-announce-omicron-adapted-covid-19Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine ...

    25 cze 2022 · COMIRNATY® (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. COMIRNATY® is administered as a 2-dose primary series.

  5. www.fda.gov › media › 167212FACT SHEET FOR RECIPIENTS AND CAREGIVERS ABOUT PFIZER-BIONTECH...

    22 sie 2024 · Under the authorized dosing schedule, these individuals receive the Pfizer-BioNTech COVID−19 Vaccine before they turn 12 years old, and complete the vaccination series with COMIRNATY on or...

  6. www.ema.europa.eu › en › newsFirst adapted COVID-19 booster vaccines recommended for approval...

    1 wrz 2022 · EMA’s human medicines committee (CHMP) has recommended authorising two vaccines adapted to provide broader protection against COVID-19. Comirnaty Original/Omicron BA.1 and Spikevax bivalent Original/Omicron BA.1 are for use in people aged 12 years and above who have received at least primary vaccination against COVID-19.

  7. www.fda.gov › pfizer-biontech-covid-19-vaccinePfizer-BioNTech COVID-19 Vaccine | FDA

    11 wrz 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19. The Pfizer-BioNTech...